Saturday, April 4, 2015

Best Industrial Disributor Stocks To Own Right Now

Best Industrial Disributor Stocks To Own Right Now: U.S. Energy Corp.(USEG)

U.S. Energy Corp. engages in the acquisition, exploration, holding, sale, and/or development of mineral properties. It primarily explores for molybdenum, and other base and precious metals. The company holds interests in Mount Emmons property that covers approximately 9,311 acres located in Gunnison County, Colorado. It also holds interests in oil and gas properties located in Williston Basin North Dakota and Gulf Coast region. In addition, the company holds interests in geothermal properties. Further, it develops multifamily apartment project in Gillette, Wyoming. As of December 31, 2009, its estimated proved reserves were approximately 1,086,203 BOE. The company was founded in 1966 and is based in Riverton, Wyoming.

Advisors' Opinion:
  • [By Roberto Pedone]


    US Energy (USEG), an independent energy company, focuses on the acquisition and development of oil and gas producing properties in the continental U.S. This stock closed up 6.9% to $3.53 in Thursday's trading session.


    Thursday's Range: $3.29-$3.53

    52-Week Range: $1.45-$4.06

    Thursday's Volume: 116,000

    Three-Month Average Volume: 219,710


    From a technical perspective, USEG bounced sharply higher here right off some near-term support at $3.27 and back above its 50-day moving average of $3.45 with lighter-than-average volume. This stock recently formed a triple bottom chart pattern at $3.32, $3.21 and $3.27. Since finding buying interest at those levels, shares of USEG are now spiking higher and moving within range of triggering a near-term breakout trade. That trade will hit if USEG manages to take out some near-term overhead resistance levels at $3.65 to $3.80 with high volume.


    Traders should now look for long-biased trades in USEG as long as it's trending above some key near-term support levels at $3.27 or at $3.21 and then once i! t sustains a move or close above those breakout levels with volume that hits near or above 219,710 shares. If that breakout hits soon, then USEG will set up to re-test or possibly take out its 52-week high at $4.06. Any high-volume move above that level will then give USEG a chance to tag its next major overhead resistance levels at $4.60 to $5.


  • source from Top Stocks To Buy For 2015:

Friday, April 3, 2015

Top 5 Dow Dividend Companies To Own For 2015

Top 5 Dow Dividend Companies To Own For 2015: CSS Industries Inc (CSS)

CSS Industries, Inc. (CSS), incorporated on November 5, 1923, is a company primarily engaged in the design, manufacture, procurement, distribution and sale of seasonal and all occasion social expression products, principally to mass market retailers. These seasonal and all occasion products include gift wrap, gift bags, gift boxes, gift card holders, boxed greeting cards, gift tags, decorative tissue paper, decorations, classroom exchange Valentines, decorative ribbons and bows, floral accessories, Halloween masks, costumes, make-up and novelties, Easter egg dyes and novelties, craft and educational products, stickers, memory books, stationery, journals, notecards, infant and wedding photo albums, scrapbooks, and other gift items that commemorate lifes celebrations. In September 5, 2012, it sold the Halloween portion of its Paper Magic business to Gemmy Industries (HK) Limited.

CSS product provides its retail customers the opportunity to use a single ven dor for much of their seasonal product requirements. A substantial portion of CSS products are manufactured, packaged and/or warehoused in 10 facilities located in the United States, with the remainder purchased primarily from manufacturers in Asia and Mexico. The Companys products are sold to its customers by national and regional account sales managers, sales representatives, product specialists and by a network of independent manufacturers representatives. The Companys principal operating subsidiaries include Paper Magic Group, Inc. (Paper Magic), Berwick Offray LLC (Berwick Offray) and C.R. Gibson, LLC (C.R. Gibson). CSS designs, manufactures, procures, distributes and sells a range of seasonal consumer products primarily through the mass market distribution channel. Christmas products include gift wrap, gift bags, gift boxes, gift card holders, boxed greeting cards, gift tags, decorative tissue paper and decorations. CSS Valentine product offerings incl! ud e classroom exchange Valentine cards and other related Valentine products, while its Easter product offerings include Dudleys brand of Easter egg dyes and related Easter seasonal products. CSS also designs and markets decorative ribbons and bows, all occasion boxed greeting cards, gift wrap, gift bags, gift boxes, gift card holders, decorative and waxed tissue, decorative films and foils, stickers, memory books, stationery, journals, notecards, infant and wedding photo albums, scrapbooks, floral accessories and other gift and craft items to its mass market, craft, specialty and floral retail and wholesale distribution customers, and teachers' aids and other learning oriented products to the education market through mass market retailers, school supply distributors and teachers' stores. Key brands include Paper Magic, Berwick, Offray, C.R. Gibson, Markings, Creative Papers, Tapestry, Dudleys, Don Post Studios, Eureka, Learning Playground, Stickerfitti and iota. Key bran ds include Paper Magic, Berwick, Offray, C.R. Gibson, Markings, Creative Papers, Tapestry, Seastone, Dudleys, Eureka, Learning Playground and Stickerfitti.

CSS operates 10 manufacturing and/or distribution facilities located in Pennsylvania, Maryland, New Hampshire, South Carolina, Alabama and Texas. Its boxed greeting cards are produced by Asian manufacturers to the Companys specifications. Halloween make-up and Easter egg dye products are manufactured in Asia to specific formulae by contract manufacturers who meet regulatory requirements for the formularization and packaging of such products. Ribbons and bows are primarily manufactured and warehoused in seven facilities located in Pennsylvania, Maryland, South Carolina and Texas. Memory books, stationery, journals and notecards, infant and wedding photo albums, scrapbooks, and other gift items are imported from Asian manufacturers and warehoused and distributed from a distribution facility in Florence, A labama. Floral accessories, including pot covers, foil, waxed ti! ssue, shr! ed, aisle runners, corsage bags and other paper and film products, are manufactured in a facility located in Milford, New Hampshire and Juarez, Mexico. Manufacturing includes gravure and flexo printing, waxing and converting. Products are warehoused and distributed from a distribution facility in Berwick, Pennsylvania. Other products including, but not limited to, decorative tissue paper, all occasion gift wrap, gift tags, gift bags, gift boxes, gift card holders, classroom exchange Valentine products, Halloween masks, costumes and novelties, Easter products, decorations and school products are designed to the specifications of CSS and are imported primarily from Asian manufacturers.

Advisors' Opinion:
  • [By Rich Duprey]

    Gifts makerCSS Industries (NYSE: CSS  ) announced yesterday its second-quarter dividend of $0.15 per share, the same rate it's paid since 2008.

  • source from Top Stocks To Buy For 2015:

Thursday, April 2, 2015

If You Hear Calls for a Market Crash, Don't Panic... Read This

Top 5 Oil Stocks To Watch Right Now

There's big news going around the Stansberry & Associates office this month...   In his latest issue, our colleague Porter Stansberry told readers of his research service to prepare for a major market decline.   Porter believes all the borrowing and money printing going on at the world's central banks will produce a crisis that upends the currency, bond, and stock markets.   He's urging his readers to sell many (but not all) of their stock positions.   Porter is one of the most widely followed investment analysts in America... and he has a good track record with big market calls like this.   So what should you do about it?    If you're a trader, you should be focused on limiting risk first and maximizing profits second. So it's worth thinking about how you would handle the kind of scenario Porter sees coming.   Fortunately, there's a very simple, safe plan available...   You let the market decide.   As we often say in our DailyWealth Trader service, the market is the judge, jury, and executioner of every trade. That's why we use predetermined stop prices on all our positions. If a stock we're following declines by a set amount, we exit the trade. If it doesn't... we can continue collecting profits.   We've seen both scenarios at work this year.    Back in October, for example we recommended oil-services firm C&J Energy Services (NYSE: CJES). After our write-up, the stock jumped from about $19 to $25.   When you see a big, fast gain like that, it's a good idea to take steps to protect it. So we suggested tightening the stop loss on the trade...   C&J Energy Services (CJES) Hits Its Stop   We moved closer to the exit... and then the market told us it was time to go. While C&J's share price completed a "round trip" back down into the high teens this spring, readers who followed our advice walked away with a 17% gain.    It doesn't always work that way, of course. Our readers bought shares of drugstore giant Walgreens (WAG) in early 2012. By February of this year, the position was showing a 33% gain. And we suggested tightening the stop loss.   Walgreens (WAG) Has Not Yet Hit Its Stop   Afterward, shares marched higher. Even after the recent market weakness, they're a chip-shot away from a new all-time high. Our readers can continue to make gains here until the market tells them otherwise.    The S&P 500 ran up as much as 23% from its November bottom. In other words, the market packed two years' worth of gains into a matter of months. And many stocks soared to new all-time highs.   That was a "gift from the market gods." So if you're sitting on big gains today, it's a good idea to take steps to protect them. Consider tightening up your stops.    We can't say whether the crisis Porter predicts is around the corner. Nobody can. It could be six months away... two years away... or not there at all.   Fortunately, you don't have to guess or predict. You can stay long your winning trades... and benefit if there's more upside... and use exit strategies that will protect your profits and capital if a downtrend occurs.   If you've planned the trades, all you need to do is trade the plan.   – Amber Lee Mason and Brian Hunt

Wednesday, April 1, 2015

The 3 Deadliest Diseases Caused by Smoking

Unless you've been hiding under a rock, you're probably well aware of the dangers associated with smoking tobacco and have witnessed the increasing efforts of the Centers for Disease Control and Prevention to step up its educational efforts over the past two decades.

The good news is that the number of smokers in the United States is on the decline, with just 19% of U.S. adults listed as current smokers by the CDC.

Source: Centers for Disease Control and Prevention.

Targeted advertising that's graphic, educational, and focused on America's youth has instilled the dangers of smoking into much of the younger generation. The CDC, for example, kicked off its first-ever anti-smoking television campaign last year, spending $54 million over the course of three months with the express purpose of causing at least 50,000 people to quit.

Source: Linus Bohman, Flickr.

The reason to encourage smokers to quit is much more than "it's just bad for you"; scientifically and economically it's been shown that smoking can affect our friends and family and harm productivity in the workplace. Secondhand smoke, for instance, has been shown to increase the probability that our friends and family will develop a disease directly caused by cigarette smoke inhalation. In addition, U.S. businesses lose about $97 billion in productivity each year because of disease-related complications caused by cigarette smoking. Keep mind this figure is just based on productive work-lives shortened by cigarette smoking and doesn't include lost production because of disability and sick days.

However, nothing stands out as more glaring than the deaths that are directly attributable to cigarette smoking -- an average of 443,000 annually between 2000 and 2004, according to the CDC. Today I propose to examine the three most deadly diseases caused by cigarette smoking and analyze what medications are available to help treat those diseases.

This is something of a no-brainer, but cancer was responsible for 164,200, or 37%, of the total deaths attributable to cigarette smoking. If you recall, smoking was practically a universal risk factor across the board when I examined the 12 most commonly diagnosed cancers in the Tackling Cancer series earlier this year.

Of the attributed smoking deaths associated with cancer, none is more virulent than lung cancer which singlehandedly claimed an average of 128,900 lives annually between 2000 and 2004. Based on the CDC's statistics, the risk of developing lung cancer by smoking cigarettes increases by a factor of 23 for men and 13 for women relative to non-smokers, while five-year survival rates for lung cancer sit at just a dismal 12%.

Perhaps no drug is more widely used in lung cancer treatment than Roche's Avastin. Roche's wonder drug is an angiogenesis inhibitor, simply meaning that it inhibits the growth of blood vessels to tumors in the hope of starving a solid tumor of the oxygen needed for it to grow. When Avastin was approved in 2006, it improved median overall survival in patients to 12.3 months from 10.3 for the control arm. Relatively speaking, though, we need to do a lot better than just 12.3 months! 

The next step in lung cancer care treatment may come from the likes of Bristol-Myers Squibb's nivolumab or Merck's (NYSE: MRK  ) lambrolizumab. Both of these drugs are known as PD-1 inhibitors which have shown reasonably high overall response rates in clinical trials – 40% for nivolumab and 38% for lambrolizumab – and could represent the next treatment pathway for lung cancer patients. Nivolumab is currently in six in late-stage trials, including the treatment of non-small-cell lung cancer, while Merck's lambrolizumab has received the rare breakthrough therapy designation from the FDA, which could help streamline its approval if it continues to provide a huge statistical benefit in trials over existing treatments. 

Ischemic heart disease
Closely trailing cancer as the most deadly smoking-related cause of death is ischemic heart disease, which was responsible for 126,000, or 28%, of all deaths. Ischemic heart disease is a condition in which the heart doesn't receive enough blood flow, which can be caused by a number of factors, including high blood pressure (hypertension), high cholesterol, and diabetes. Once again, and as no surprise, smoking is a major risk factor for developing all three diseases!

Unlike a cancer diagnosis, which pretty specifically cued in on lung cancer relative to all other cancer diagnoses combined by a margin of greater than 3-to-1, ischemic heart disease can develop as a result of any one, or a combination of, the aforementioned diseases. This means that in addition to quitting smoking, and living an active life with a proper diet, certain medications may be called upon to help regulate a person's cardiovascular system.

Novartis' Diovan, for example, is a widely prescribed treatment for helping patients with high blood pressure. Diovan is an angiotensin II receptor blocker, meaning that it prevents angiotensin from affecting blood vessels, ultimately relaxing them and allowing blood to flow more easily. Although Diovan lost its patent protection last year, no biosimilar version of the drug has made it to market as of yet. 

The new kid on the block in treating LDL-cholesterol (the bad type) is Liptruzet, a combination therapy of Pfizer's (NYSE: PFE  ) generic Lipitor and Merck's cholesterol absorption inhibitor, Zetia. Separately, these two drugs were effective at reducing LDL-cholesterol levels by 37% to 54%, and 20%, respectively. However, when combined the combination, known as Liptruzet, boosted the LDL-reducing effect to 53%-61%. It looks like the legend of Lipitor, the best-selling drug in history, will live on!

With regard to diabetes, it really just depends whether you're dealing with the genetic and rarer form of the disease, type 1 diabetes, or the much more common type 2 diabetes, whose onset is based on a number of factors that includes diet, activity level, and genetics. For the sake of argument -- and to take nothing away from type 1 diabetes patients, who recently had an encouraging discovery of their own -- Johnson & Johnson's (NYSE: JNJ  ) new SGLT-2 inhibitor, Invokana, looks to be the next big thing in type 2 diabetes treatment. Working in the kidneys instead of the liver or pancreas, Invokana allows the body to excrete excess glucose through the urine. Better yet, Invokana has also been shown to induce weight loss (which can be a good thing since a majority of diabetics are overweight) and reduce hypertension.

Chronic obstructive pulmonary disease
Not to be forgotten is chronic obstructive pulmonary disorder, better known as COPD, which was responsible for 92,900, or 21%, of all cigarette smoking-related deaths from 2000 to 2004. COPD is already the third-leading cause of death in the U.S., slightly ahead of stroke, and comes in two primary forms: chronic bronchitis, which is exhibited by a long-term cough with mucus production, and emphysema, an irreversible and progressive degradation of the lungs over time.

Perhaps the most exciting new treatment to hit the market in years was recently approved by the FDA. Developed by GlaxoSmithKline (NYSE: GSK  ) and Theravance (NASDAQ: THRX  ) , Breo Ellipta is a dry powder drug delivered by inhaler and meant to provide long-term relief of air-flow obstruction and reduce COPD exacerbations. The two companies are collaborating on a handful of potentially revolutionary new COPD treatments that combine Theravance's long-acting beta-2 agonists with Glaxo's long-acting muscarinic antagonists. Its next treatment, Breo Anoro, is currently under review by the FDA.

Source: Centers for Disease Control and Prevention.

The butt of the problem
The negative effects of cigarette smoking on our bodies is quite clear no matter where we look for our evidence. If you choose to smoke, your likelihood of developing one of these three deadly diseases, which were responsible for 86.5% of all smoking-related deaths, is greatly increased.

If we've learned anything here today, it's that quitting smoking could be one of the healthiest and smartest moves you ever make as it could drastically reduce your chances of developing a serious illness, and that tobacco is quite addictive -- otherwise, most people would have stopped smoking a long time ago. This means that while we are seeing a minimal reduction in the percentage of U.S. smokers, the need for medications to treat lung cancer, COPD, and various forms of ischemic heart disease aren't likely to slow anytime soon.

Obamacare will undoubtedly have far-reaching effects. The Motley Fool's new free report "Everything You Need to Know About Obamacare" lets you know how your health insurance, your taxes, and your portfolio could be affected. Click here to read more. 

Tuesday, March 31, 2015

Top 5 Clean Energy Stocks To Watch Right Now

Top 5 Clean Energy Stocks To Watch Right Now: Cambridge Bancorp (CATC)

Cambridge Bancorp, incorporated on December 23, 1982, is a state chartered, federally bank holding company in Cambridge. The Company's reportable operating segment consists of commercial banking, consumer banking, and trust and investment management services. Cambridge Trust Company (the Bank) is a subsidiary of the Company. The Bank offers a range of commercial and consumer banking services through its network of 12 service banking offices in Massachusetts. The Bank is engaged in the business of attracting deposits from the public and investing those deposits. The Bank invests those funds in various types of loans, including residential and commercial real estate, and a variety of commercial and consumer loans. The Bank also invests its deposits and borrowed funds in investment securities and has three wholly owned Massachusetts Security Corporations, CTC Security Corporation, CTC Security Corporation II and CTC Security Corporation III.

Lending activities< /p>

The Bank originates loans to businesses and individuals on both a collateralized and an uncollateralized basis. The Bank's customer base is concentrated in eastern Massachusetts. The majority of loans to individuals are collateralized by residential real estate, marketable securities or other assets.

Investment activities

The Bank invests in United States government sponsored enterprise (GSE) obligations, mortgage-backed securities, mutual funds and municipal securities. As a member of the Federal Home Loan Bank (FHLB) of Boston (the FHLB Boston), the Bank is required to invest in stock of the FHLB Boston in an amount based upon itsadvances from the FHLB Boston.

Sources of Funds

The Bank attracts deposits, such as demand deposits (non-interest bearing), interest bearing checking, money market, s! avings, certificates of deposit under $100,000 and certificates of deposit $100,000 or greater. Its short term borro wings consist of treasury, tax and loan notes, and FHLB Bost! on overnight borrowings.

Advisors' Opinion:
  • [By CRWE]

    Last Friday, CATC previously surged (+0.26%) up +0.10 at $39.00 with 600 shares in play at the close (ref. google finance July 26, 2013 – Close).

    Cambridge Bancorp previously reported unaudited net income of $3,475,000 for the second quarter of 2013 compared to $3,451,000 for the same quarter in 2012. The slight increase in earnings was primarily attributable to growth in noninterest income, offset by a decrease in net interest income. Diluted earnings per share were $0.89 for the second quarter of 2013, unchanged versus for the same quarter in 2012. For the six months ended June 30, 2013, unaudited net income was $6,806,000 compared to $6,736,000 for the first half of 2012. Diluted earnings per share were $1.75 for the first six months of 2013 versus $1.74 for the same period in 2012.

  • [By CRWE]

    Today, CATC has shed (-0.26%) down -0.10 at $38.90 with 500 shares in play thus far (ref. google finance Delayed: 11:24AM EDT July 22, 2013), but don't let this get you down.

    Cambridge Bancorp previously reported unaudited net income of $3,475,000 for the second quarter of 2013 compared to $3,451,000 for the same quarter in 2012. The slight increase in earnings was primarily attributable to growth in noninterest income, offset by a decrease in net interest income. Diluted earnings per share were $0.89 for the second quarter of 2013, unchanged versus for the same quarter in 2012. For the six months ended June 30, 2013, unaudited net income was $6,806,000 compared to $6,736,000 for the first half of 2012. Diluted earnings per share were $1.75 for the first six months of 2013 versus $1.74 for the same period in 2012.

  • source from Top Stocks For 2015:h! ttp://www!

Hot Heal Care Stocks To Watch For 2014

This was supposed to be the year the "Great Rotation" from bonds to stocks would hit Maserati-like acceleration.

Well, the great stock market sell-off of 2014 has put the expected asset allocation shift from fixed-income investments to stocks on hold.

In the exchange-traded-fund (ETF) space, investors pulled $14.7 billion out of U.S. stock-focused funds in January ��the largest outflow since August 2013 ��snapping four straight months of inflows, according to Birinyi Associates. Last month, the Standard & Poor's 500-stock index fell 3.6% and suffered its first down January in four years.

In contrast, $624 million flowed into long-term U.S. government bonds.

MARKETS: Stocks fail to gain traction, close slightly lower

TRACK YOUR STOCKS: Get real-time quotes with our free Portfolio Tracker

Top 10 Computer Hardware Companies To Invest In Right Now: Universal Technical Institute Inc(UTI)

Universal Technical Institute, Inc. engages in the provision of postsecondary education for students seeking careers as professional automotive, diesel, collision repair, motorcycle, and marine technicians in the United States. It offers undergraduate degree, diploma, and certificate programs through its campuses under various brands, including Universal Technical Institute, Motorcycle Mechanics Institute and Marine Mechanics Institute, and NASCAR Technical Institute. The company also provides manufacturer-specific training programs comprising student paid electives at its campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Universal Technical Institute, Inc. was founded in 1965 and is headquartered in Scottsdale, Arizona.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Universal Technical Institute (NYSE: UTI  ) , whose recent revenue and earnings are plotted below.

  • [By Laura Brodbeck]


    Earnings Expected From: Bank of Montreal (NYSE: BMO), United Natural Foods, Inc. (NASDAQ: UNFI), OmniVision Technology, Inc. (NASDAQ: OVTI), Universal Technical Institute, Inc. (NYSE: UTI) Economic Releases Expected: Chinese HSBC Services PMI, Australian GDP, Brazilian GDP, eurozone PPI, British construction PMI.


Hot Heal Care Stocks To Watch For 2014: Express-1 Expedited Solutions Inc.(XPO)

XPO Logistics, Inc. provides third-party logistics services using a network of relationships with ground, sea, and air carriers in the United States, Mexico, and Canada. It operates in three segments: Express-1, Concert Group Logistics, and Bounce Logistics. The Express-1 segment offers ground expedited surface transportation services for freight. It operates a fleet ranging from cargo vans to semi tractor trailer units. The Concert Group Logistics segment provides domestic and international freight forwarding services through a network of independently owned stations. Its domestic freight forwarding services include air charter, expedites, and time sensitive services, as well as cost sensitive services comprising deferred delivery, less than truckload, and full truck load services; and international freight forwarding services consist of on-board courier and air charters, time sensitive services, less-than-container and full-container-loads, and vessel charters. This segm ent also offers documentation on international shipments, customs clearance and banking, trade show shipment management, time definite and customized product distributions, reverse logistics and on site asset recovery projects, installation coordination, freight optimization, and diversity compliance support services. The Bounce Logistics segment provides premium freight brokerage services for truckload shipments. The company serves approximately 4,000 retail, commercial, manufacturing, and industrial customers through 6 U.S. operations centers and 22 agent locations. It offers its services to the automotive manufacturing, automotive components and supplies, commercial printing, durable goods manufacturing, pharmaceuticals, food and consumer products, and high tech sectors. The company was formerly known as Express-1 Expedited Solutions, Inc. and changed its name to XPO Logistics, Inc. in September 2011. XPO Logistics, Inc. was founded in 1989 and is based in Buchanan, Michi gan.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    XPO Logistics (NYSE: XPO) shot up 7.06 percent to $30.01 after the company announced its plans to acquire Pacer International (NASDAQ: PACR) in a deal valued at $335 million.

  • [By Travis Hoium]

    What: Shares of XPO Logistics (NYSE: XPO  ) jumped 13% today after announcing an acquisition.

    So what: The company will pay $365 million for logistics provider 3PD, consisting of $357 million in cash an $8 million in XPO restricted stock. Is will use its own cash and borrow $195 million from Credit Suisse Group for the remainder of the purchase. �

  • [By Vera Yuan]

    We initiated a new position in Aircastle Ltd. (AYR), an aircraft leasing company with a flexible business model and a rational capital allocation philosophy. We took advantage of an opportunity to purchase shares in the heavily capitalized Georgia bank State Bank Financial Corp. (STBZ) as the depressed stock price reflected investors��lack of patience with a slower than expected pace of capital deployment. We like State Bank�� management team led by Georgia banker Joe Evans. This management team has experience successfully building and selling other Georgia banks. We also received shares of transportation infrastructure company XPO Logistics, Inc. (XPO) as a result of its acquisition of holding Pacer International, Inc.

Hot Heal Care Stocks To Watch For 2014: Greengro Technologies Inc (GRNH)

GreenGro Technologies Inc., formerly Authoriszor Inc., provides management services for the planning, construction, staffing and operation of medical marijuana dispensaries, and nurseries on behalf of non-profit patient co-operatives. Through long term contracts, the Company operates non-profit centers, returning all unused patient contributions, on a pro-rata basis to each co-op member in the form of additional product. In February 2010, Authoriszor Inc. completed the acquisition of GreenGro Technologies, Inc., and CannovaHealth, a clinic management company. In September 2011, the Company acquired Vertical Hydrogarden, Inc.

Medical marijuana (medical cannabis) is an alternative method to other forms of medication used to manage or alleviate pain without the undo side-effects caused by the prescription medication being used to treat an illness. The Company stands ready to assist in patient care co-operatives throughout the United States.

Advisors' Opinion:
  • [By Dan Burrows]

    But it doesn’t end there. Investors should run away from all OTC marijuana stocks, including Medical Marijuana (MJNA), Cannabis Science (CBIS), CannaVest (CANV), MediSwipe (MWIP) and GreenGro Technologies (GRNH). As the SEC warns:

  • [By Ben Levisohn]

    But, as the Huffington Post points out, most of the companies that stand to benefit are very small–they make micro caps look big–trade over the counter–good bye liquidity. That includes transaction-processing company MediSwipe (MWIPD), GreenGro Technologies (GRNH) Medbox (MDBX), which makes dispenser for high-risk drugs, and GW Pharmaceuticals (GWPRF).

Hot Heal Care Stocks To Watch For 2014: iShares MSCI Russia Capped ETF (ERUS)

iShares MSCI Russia Capped ETF (the Fund), formerly iShares MSCI Russia Capped Index Fund,, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the MSCI Russia 25/50 Index (the Underlying Index). The Underlying Index is a free-float adjusted market capitalization weighted index designed to measure the performance of equity securities in the top 85% by market capitalization of equity securities listed on stock exchanges in Russia. The Underlying Index is a customized variation of the MSCI Russia Index, designed to cap certain weightings to take into account the investment diversification requirement applicable to regulated investment companies. The Fund�� investment advisor is BlackRock Fund Advisor. Advisors' Opinion:
  • [By Barbara Kollmeyer]

    As for U.S. investor exposure, the pain was there for all to see as the week wound down. Among exchange-traded funds, the iShares MSCI Russia ETF (ERUS) �and the SPDR S&P Russia ETF (RBL) �each fell more than 6% for the week, contrasting with a 0.1% gain for the iShares MSCI Emerging Markets ETF (EEM) .

Monday, March 30, 2015

Top 5 Industrial Disributor Companies To Own In Right Now

Top 5 Industrial Disributor Companies To Own In Right Now: Inchcape PLC (INCH)

Inchcape plc is a global premium automotive distributor and retailer. The Company provides a professional and financed route to market for automotive manufacturers across five continents. Inchcape acts as a vehicle and parts distributor in 22 of its 26 markets. In these markets, the Company has responsibility for managing the value chain on behalf of a focused portfolio of premium and luxury brand partners. The Companys responsibilities as a distributor include specifying vehicles to meet local market requirements, organizing logistics from the factory gate through to the retail center, appointing and performance managing the retail network and acting as the national marketer of the brand. The Company derives over two third of its profit from Asia Pacific and emerging markets. Its markets include Hong Kong, Singapore, Russia, Chile, Ethiopia, Australia and the United Kingdom. Advisors' Opinion:
  • [By Inyoung Hwang]

    Inchcape Plc (INCH) surged 9.9 percent to 645 pence, the highest level since June 2008. The largest publicly traded U.K. car retailer and wholesaler reported first-half adjusted pretax earnings increased 11 percent. The company also announced share buybacks of 100 million pounds in the next year.

  • source from Top Stocks To Buy For 2015:

Sunday, March 29, 2015

Hot India Companies To Own For 2015

Hot India Companies To Own For 2015: Infosys Technologies Limited(INFY)

Infosys Ltd. provides information technology (IT) and consulting services worldwide. It offers IT services, such as application, architecture, independent validation and testing, information management, infrastructure, packaged application, SOA, systems integration, and knowledge services; product engineering services, manufacturing process and plant solutions, and product lifecycle management services; and consulting services in the areas of information and technology strategies, product innovation, next generation commerce, process excellence, and learning and complex change. The company also provides business process outsourcing solutions in the areas of business platforms, customer service outsourcing, finance and accounting, human resources outsourcing, legal services, sales and fulfillment, and sourcing and procurement outsourcing. In addition, it offers collaborative analytics solutions; digital consumer platform; Finacle universal banking solution; iProwe, a Web ac cessibility assessment product; mConnect, a real-time enterprise middleware; and research and analytical support services. Further, the company offers unified communications and collaboration solution that streamlines business processes between employees, customers, and suppliers; iTransform that helps healthcare organizations accelerate transition to new platforms; and supply chain visibility and collaboration product suite. It serves aerospace and defense, airlines, automotive, banking, capital markets, communication services, consumer packaged goods, manufacturing, education, energy, healthcare, high technology, hospitality and leisure, insurance, life sciences, logistics and distribution, publishing, resources, utilities, and retail industries. Infosys Ltd. has a strategic partnership with Alstom SA. The company was formerly known as Infosys Technologies Limited an! d changed its name to Infosys Ltd. on June 16, 2011. Infosys Ltd. was founded in 1981 and is headquartered i n Bengaluru, India.

Advisors' Opinion:
  • [By Laura Brodbeck]

    Next week investors will be waiting for several key earnings reports including Wells Fargo & Company (NYSE: WFC), Alcoa (NYSE: AA), Family Dollar Stores (NYSE: FDO) and Infosys Limited (NASDAQ: INFY).


    Vanguard favors India with investments in Infosys Ltd. (NSE: INFY), Reliance Industries Ltd. (NSE: RELIANCE), and Housing Development Finance Corp. Ltd. (NSE: HDFC) ranking among its top 20.

  • [By Robert Martin]

    Infosys (INFY), Housing Development Finance and Reliance Industries LTD are the top three holdings, with weightings between 8% and 10.5%. Of course, just about any India ETF will have a heavy  allocation to Infosys and Reliance. However, INDA dedicates a lower percentage to energy than some of the alternatives, and instead leans more on IT and consumer spending.

  • [By Aaron Smith]

    The government accused software developer Infosys (INFY) of using workers with B-1 visas, which only allow temporary entry into the U.S. for business purposes, to perform skilled labor jobs.

  • source from Top Stocks For 2015: